Clinical Updatesvanishing white matterpediatric neurodegeneration
Safety and Efficacy of Guanabenz in Early-Childhood Onset Vanishing White Matter: Insights from a Phase 1/2 Single-Arm Trial
By MedXY|Sep 5, 2026
This review synthesizes recent evidence demonstrating guanabenz’s manageable safety profile and efficacy in delaying ambulatory decline in early-onset vanishing white matter disease, highlighting translational pharmacokinetic data and
